Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 


Aurora kinase inhibitor
BML-SC104-0005 5 mg 132.00 USD
Do you need bulk/larger quantities?
Induces dedifferentiation in murine C2C12 myoblasts. The cells were also shown to regain multipluripotency following removal of the compound. Potent and selective A3 adenosine receptor antagonist (Ki = 0.66µM) and a novel aurora kinase inhibitor (IC50's of 30-550nM for blast colony formation assay).

Product Specification

Alternative Name:2-(4-Morpholinoanilino)-6-cyclohexylaminopurine
Purity:≥98% (TLC)
Appearance:Pale gray solid.
Solubility:Soluble in DMSO (10mg/ml).
Shipping:Shipped on Blue Ice
Long Term Storage:-20°C
Use/Stability:Store, as supplied, at -20°C for up to 1 year.  Store solutions at -20°C for up to 3 months.
Regulatory Status:RUO - Research Use Only
BMl-SC104 Structure
Please mouse over
BMl-SC104 Structure

Product Literature References

Probing the catalytic functions of Bub1 kinase using the small molecule inhibitors BAY-320 and BAY-524: A.P. Baron, et al.; eLife 5, e12187 (2016), Application(s): Cell culture, Abstract; Full Text
The NOXA-MCL1-BIM axis defines lifespan on extended mitotic arrest: M.D. Haschka, et al.; Nat. Commun. 6, 6891 (2015), Application(s): Cell Culture, Abstract; Full Text
Reversine, a novel Aurora kinase inhibitor, inhibits colony formation of human myeloid leukemia cells.: A.M. D'Alise, et al.; Mol. Cancer Ther. 7, 1140 (2008), Abstract; Full Text
"Reversine" and it's 2-Substituted Adenine Derivatives as Potent and Selective A3 Adenosine Receptor Antagonists: M. Perreira, et al.; J. Med. Chem. 48, 4910 (2005), Abstract;
Dedifferentiation of Lineage-Committed Cells by a Small Molecule: S. Chen, et al.; JACS 126, 410 (2004), Abstract;

Product Toolbox


Certificate of Analysis


By target:
Aurora kinase
Adenosine receptor
By biological activity:
Aurora kinase Inhibitor
Adenosine receptor Blocker
By catalog section:


Technical Service
Customer Service

Recommend this page

Keep in touch

©2020 Enzo Life Sciences, Inc.,